A class action lawsuit has been filed by leading law firm Berger Montague PC against MoonLake Immunotherapeutics (NASDAQ: MLTX) on behalf of investors who bought the Company's shares between March and December 2025. The suit alleges misconduct causing financial harm to shareholders. Details of the case include specific dates and actions taken by MoonLake.